EXPRESS-V: Exercise as a Primer for Brain Stimulation in Vascular Cognitive Impairment No Dementia (VCIND)

Sponsor
Sunnybrook Health Sciences Centre (Other)
Overall Status
Recruiting
CT.gov ID
NCT05079464
Collaborator
(none)
80
1
4
33.3
2.4

Study Details

Study Description

Brief Summary

People with vascular conditions are at risk of having memory problems, and these memory problems increase the risk for further cognitive decline. Brain stimulation has been used to improve mood and memory. Transcranial direct current stimulation (tDCS) is believed to work best on brain cells that are active or "primed" before stimulation. The purpose of this study is to compare the effects of exercise and tDCS on memory performance in patients who have completed cardiac rehabilitation and are at risk of cognitive decline.

Condition or Disease Intervention/Treatment Phase
  • Other: tDCS
  • Other: Exercise
  • Other: Sham stimulation
  • Other: Treatment as usual
N/A

Detailed Description

Vascular disease is a major risk factor and contributor to dementia. Current interventions to manage vascular risk factors have mixed results. Presently, there are no consistently effective treatments targeting vascular cognitive impairment no dementia.

Study Aim: To evaluate the effect of exercise-primed tDCS on global cognition.

Study Design: Eligible participants will be randomized to one of four interventions: Exercise primer with tDCS, Treatment as usual (TAU/exercise education) with tDCS, or Exercise primer with sham tDCS, Treatment as usual with sham tDCS. Participants randomized to an exercise group will undergo exercise, followed by either sham or active tDCS. Participants randomized to TAU will receive written information in accordance with the Canadian Physical Activity Guidelines for older adults and tDCS or sham. Cognition, behaviour, neuroimaging and blood biomarkers will be measured.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized, blinded, repeated-session, parallel-design studyRandomized, blinded, repeated-session, parallel-design study
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Participants, outcomes assessors, and investigators will be blinded to stimulation type.
Primary Purpose:
Treatment
Official Title:
Exercise as a Primer for Excitatory Stimulation Study in Vascular Cognitive Impairment No Dementia (EXPRESS-V)
Actual Study Start Date :
Nov 22, 2021
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise primed tDCS

Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by active tDCS.

Other: tDCS
All participants randomized to tDCS will receive active tDCS

Other: Exercise
Participants will exercise at Toronto Rehab.

Other: Exercise primed Sham stimulation

Individuals randomized to this group will receive exercise at University Health Network-Toronto Rehabilitation Institute followed by sham tDCS.

Other: Exercise
Participants will exercise at Toronto Rehab.

Other: Sham stimulation
The same procedure for tDCS will be used for the sham condition, except without active current.

Other: Treatment as usual (exercise education) & tDCS

Individuals randomized to this group will receive routine advice about physical activity, and active tDCS.

Other: tDCS
All participants randomized to tDCS will receive active tDCS

Other: Treatment as usual
Exercise education/ treatment as usual will include routine advice about physical activity.
Other Names:
  • Exercise education
  • Other: Treatment as usual (exercise education) & sham stimulation

    Individuals randomized to this group will receive routine advice about physical activity, and sham tDCS.

    Other: Sham stimulation
    The same procedure for tDCS will be used for the sham condition, except without active current.

    Other: Treatment as usual
    Exercise education/ treatment as usual will include routine advice about physical activity.
    Other Names:
  • Exercise education
  • Outcome Measures

    Primary Outcome Measures

    1. Montreal Cognitive Assessment - Global Cognition [2 weeks]

      The Montreal Cognitive Assessment is a 5-minute test of global cognition and a validated tool for detecting early cognitive changes.

    Secondary Outcome Measures

    1. Cognitive domains [2 weeks]

      Cognitive domains will be measured using the 60-minute battery recommended by the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network.

    2. Behavioural measures [2 weeks]

      Behaviour will be measured with the Mild Behavioural Impairment-Checklist.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ≥50 years of age; females must be post-menopausal

    • Presence of cerebrovascular and/or cardiovascular risk factors or coronary artery disease

    • Montreal Cognitive Assessment (MoCA) <27

    • Sufficiently proficient in English

    • Must be able to exercise at a moderate intensity level

    • Presence of modest deficits (1 standard deviation below population norm) in one of the following domains: executive function, verbal memory, working memory, or visuospatial memory

    Exclusion Criteria:
    • History of stroke

    • Change in psychotropics within the last 4 weeks

    • Current benzodiazepine use due

    • Metal implants that would preclude safe use of tDCS or neuroimaging

    • Significant neurological or psychiatric conditions (current major depressive disorder, bipolar disorder, schizophrenia)

    • MoCA <18 and/or clinical diagnosis of dementia

    • Any medical contraindications to exercise

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5

    Sponsors and Collaborators

    • Sunnybrook Health Sciences Centre

    Investigators

    • Principal Investigator: Krista Lanctôt, PhD, Sunnybrook Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sunnybrook Health Sciences Centre
    ClinicalTrials.gov Identifier:
    NCT05079464
    Other Study ID Numbers:
    • 3348
    First Posted:
    Oct 15, 2021
    Last Update Posted:
    Feb 28, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sunnybrook Health Sciences Centre
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 28, 2022